215 related articles for article (PubMed ID: 26308072)
1. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
Wen M; Kwon Y; Wang Y; Mao JH; Wei G
Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
[TBL] [Abstract][Full Text] [Related]
2. UBE2T knockdown inhibits gastric cancer progression.
Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Liu F; Zhu C; Gao P; Zheng S; Li C
Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
[TBL] [Abstract][Full Text] [Related]
6. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
7. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
Shuliang S; Lei C; Guangwu J; Changjie L
Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
[TBL] [Abstract][Full Text] [Related]
8. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
[TBL] [Abstract][Full Text] [Related]
9. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).
Li L; Li Q
Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
[TBL] [Abstract][Full Text] [Related]
12. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
Qiao L; Dong C; Ma B
J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
[TBL] [Abstract][Full Text] [Related]
13. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
14. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer.
Huang W; Huang H; Xiao Y; Wang L; Zhang T; Fang X; Xia X
Cell Cycle; 2022 Apr; 21(8):780-791. PubMed ID: 35130130
[TBL] [Abstract][Full Text] [Related]
15. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Ren X; Li A; Ying E; Fang J; Li M; Yu J
Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
[TBL] [Abstract][Full Text] [Related]
17. ALX1 promotes migration and invasion of lung cancer cells through increasing snail expression.
Yao W; Liu Y; Zhang Z; Li G; Xu X; Zou K; Xu Y; Zou L
Int J Clin Exp Pathol; 2015; 8(10):12129-39. PubMed ID: 26722397
[TBL] [Abstract][Full Text] [Related]
18. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription.
Li L; Liu J; Huang W
Dig Liver Dis; 2022 Jul; 54(7):937-945. PubMed ID: 34583905
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
20. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
